<DOC>
	<DOC>NCT01836757</DOC>
	<brief_summary>To delineate the effect of MSM on osteoarthritis</brief_summary>
	<brief_title>Effect of Methyl-Sulphonyl-Methane on Osteoarthritis and Cartilage</brief_title>
	<detailed_description>Objective: To delineate the effect of MSM on osteoarthritis of large joints. Design: Randomized, double-blind, placebo-controlled trial including an intervention and a placebo group. One hundred men and women, with hip and/or knee OA to be divided in 2 groups. Intervention is either MSM 3 gr twice a day for 26 weeks (6 gr/day total) for one group and placebo for the other. Outcomes measured are the Western Ontario and McMaster University Osteoarthritis Index visual analogue scale (WOMAC), patient and physician assessments and SF-36 (overall health-related quality of life).</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Dimethyl sulfone</mesh_term>
	<mesh_term>Dimethyl Sulfoxide</mesh_term>
	<criteria>Knee and hip OA men and women &gt;45 years of age any other type of arthritis chronic pain syndrome arthroscopic surgery in the past 8 months intraarticular corticosteroidsin the past 8 months hyaluronic acid injections in the past 8 months narcotic pain killers use renal or hepatic disease body mass index (BMI) &gt;45 kg/m2 cancer</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>osteoarthritis</keyword>
	<keyword>CAM treatments</keyword>
	<keyword>MSM</keyword>
</DOC>